Cancer leaves a trait of diminished immune tolerance that protects from Alzheimers disease”.
Más información
Fecha de publicación: | 2019 |
Objetivos: | Main goal: To investigate the immune checkpoint status in blood and brain tissue of patients with a history of cancer in the past compared to healthy controls, mild AD patients and patients with a history of cancer who later developed AD (Ca+AD). In two AD |
Instrumento: | FONDECYT |
Año de Inicio/Término: | 2019-2023 |
Financiamiento/Sponsor: | CONICYT |
Rol del Usuario: | COINVESTIGADOR(A) |
DOI: |
1190958 |